AstraZeneca gets EU COVID-19 third dose booster nod
Healthcare professionals can now
use AstraZeneca COVID-19 vaccine as a third dose booster in patients previously
given a primary vaccine schedule of either AstraZeneca COVID-19 vaccine or an
EU-approved mRNA COVID-19 vaccine.
The authorisation is based on a
review by the Committee for Medicinal Products for Human Use (CHMP) of the
substantial body of evidence demonstrating an increased immune response after a
third dose booster with AstraZeneca COVID-19 vaccine following a primary
vaccine schedule of either AstraZeneca COVID-19 vaccine or an mRNA COVID-19
vaccine.
Although more than 65% of the
global population has received at least one dose of a COVID-19 vaccine, there
remains a significant challenge to ensure people receive both their primary
vaccine schedule and third dose booster and healthcare professionals now have
greater flexibility in their choice of vaccine.
See also
COVID-19 exposes Africa diabetes danger
Madagascar gets US medicine backing for severe COVID-19 cases
Africa coronavirus vaccination increasing courtesy US intervention
Uganda gets WHO, Denmark 1000 oxygen cylinders to further COVID-19 battle
“The marketing authorisation for
AstraZeneca’s COVID-19 vaccine as a third dose booster is an important step
towards our goal of providing continued protection against COVID-19 for all
populations. Ensuring a longer duration of immune protection is essential to
the long-term management of COVID-19 globally and boosters can address the waning
of protection over time that has been seen with all primary vaccine schedules
to date,” Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D,
AstraZeneca, reacted.
There’s a substantial body of
evidence supporting AstraZeneca COVID-19 vaccine as a third dose booster
following all primary vaccination schedules tested to date including
AstraZeneca COVID-19 vaccine, mRNA vaccines and CoronaVac.
AstraZeneca COVID-19 vaccine is
already authorised as a homologous booster (patients previously given a primary
vaccine schedule of AstraZeneca COVID-19 vaccine) in the UK and several
countries in Asia and Latin America.
It’s also been authorised as a
heterologous booster (patients previously given a primary vaccine schedule of
either a viral vector vaccine other than AstraZeneca COVID-19 vaccine or an
inactivated vaccine or an mRNA COVID-19 vaccine) in a number of non-EU
countries.
And it’s estimated to have helped
prevent 50 million COVID-19 cases, five million hospitalisations and saved more
than one million lives based on model outcomes assessing COVID-19 worldwide.
More to see
Has humanity won its latest battle?
MultiChoice Talent Factory joins the coronavirus war
So So ... Kingg Oogbodo U Ar Wicked, COVID-19 lyrics, acoustic video
Comments
Post a Comment